#METABOLOMICS WORKBENCH Lu_Group_20220309_205810_mwtab.txt DATATRACK_ID:3121 STUDY_ID:ST002098 ANALYSIS_ID:AN003429 PROJECT_ID:PR001330
VERSION             	1
CREATED_ON             	March 10, 2022, 7:02 am
#PROJECT
PR:PROJECT_TITLE                 	Functional metabolomics-based molecular profiling of acute and chronic hepatitis
PR:PROJECT_TYPE                  	Targeted MS quantitative analysis
PR:PROJECT_SUMMARY               	Characteristics of serum metabolomics in acute and chronic hepatitis
PR:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
PR:DEPARTMENT                    	Shanghai Center for Systems Biomedicine
PR:LABORATORY                    	Lu Group
PR:LAST_NAME                     	Lu
PR:FIRST_NAME                    	Haitao
PR:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
PR:EMAIL                         	haitao_lu@sjtu.edu.cn
PR:PHONE                         	15221478139
#STUDY
ST:STUDY_TITLE                   	Functional metabolomics-based molecular profiling of acute and chronic hepatitis
ST:STUDY_TITLE                   	(Serum Metabolomics)
ST:STUDY_SUMMARY                 	Non-alcoholic steatohepatitis (NASH) is a metabolic dysregulation triggered by
ST:STUDY_SUMMARY                 	an overload disrupting the hepatic tolerance to external molecules. With the
ST:STUDY_SUMMARY                 	complexity and diversity of hepatitis triggers, no effective clinical
ST:STUDY_SUMMARY                 	classification and treatment are available, and even using the same strategies
ST:STUDY_SUMMARY                 	or approaches for acute and chronic hepatitis. For us, it is really difficult to
ST:STUDY_SUMMARY                 	precisely diagnose and treat hepatitis accordingly. To overcome this challenge,
ST:STUDY_SUMMARY                 	we integrated metabolomic, lipidomics, transcriptomics and other life science
ST:STUDY_SUMMARY                 	frontier technologies for functional metabolomics studies, and pioneered the
ST:STUDY_SUMMARY                 	redefinition of hepatitis at the molecular level. Our findings suggested that
ST:STUDY_SUMMARY                 	acute hepatitis mainly interferes with purine metabolism and amino acids
ST:STUDY_SUMMARY                 	metabolism, while chronic hepatitis mainly causes disruption of hepatic bile
ST:STUDY_SUMMARY                 	acids and lipidome, especially glycerolipids. Based on the liver-gut axis, we
ST:STUDY_SUMMARY                 	also found that the metabolic regulation of the gut microbiota is another key
ST:STUDY_SUMMARY                 	factor for chronic hepatitis development. In conclusion, functional metabolomics
ST:STUDY_SUMMARY                 	enables the cognition of disease occurrence, development and regression from
ST:STUDY_SUMMARY                 	small molecule metabolic modifications and modulations, realizing the ultimate
ST:STUDY_SUMMARY                 	goal of treating diseases and improving population health through regulation of
ST:STUDY_SUMMARY                 	dysregulated metabolism
ST:INSTITUTE                     	Shanghai Center for Systems Biomedicine, Shanghai Jiaotong University
ST:DEPARTMENT                    	Shanghai Center for Systems Biomedicine
ST:LABORATORY                    	Lu Group
ST:LAST_NAME                     	Lu
ST:FIRST_NAME                    	Haitao
ST:ADDRESS                       	800 Dongchuan RD. Minhang District, Shanghai, Shanghai, 200240, China
ST:EMAIL                         	haitao_lu@sjtu.edu.cn
ST:PHONE                         	15221478139
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-5	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-7	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-C-8	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-2	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-3	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-5	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-6	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-7	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AL-8	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-3	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-4	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-5	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-6	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-7	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-AH-8	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-3	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-5	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CL-6	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-3	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-5	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CM-6	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-3	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-6	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
SUBJECT_SAMPLE_FACTORS           	-	20210323-CH-7	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	
#COLLECTION
CO:COLLECTION_SUMMARY            	Animals were killed at 24h post the last CCl4 treatment and the serum samples
CO:COLLECTION_SUMMARY            	were harvested for further assays.
CO:SAMPLE_TYPE                   	Serum
#TREATMENT
TR:TREATMENT_SUMMARY             	Prior to experimental, animals were acclimatized breeding to laboratory
TR:TREATMENT_SUMMARY             	conditions for 1 week. The mice were randomly allocated into 6 groups (n=8
TR:TREATMENT_SUMMARY             	each), as follows: a control group (C); two acute hepatitis groups, low and high
TR:TREATMENT_SUMMARY             	concentrations (AL/ AH); three chronic hepatitis groups, low, middle and high
TR:TREATMENT_SUMMARY             	concentration (CL/ CM/ CH). Mice in chronic groups were treated 3 times per week
TR:TREATMENT_SUMMARY             	with 4 consecutive respectively intraperitoneal (i.p) injection with 1% / 5% /
TR:TREATMENT_SUMMARY             	10% CCl4 (10 mL/kg, dissolved in olive oil). However, in the acute groups, mice
TR:TREATMENT_SUMMARY             	were only intraperitoneally (i.p) injected with 1% / 5% CCl4 (10 mL/kg,
TR:TREATMENT_SUMMARY             	dissolved in olive oil) at the 12th injection. During the previous 11 times they
TR:TREATMENT_SUMMARY             	were treated the same as the healthy controls with an equal volume of olive oil.
TR:TREATMENT_SUMMARY             	Animals were killed at 24h post the last CCl4 treatment and serum, stool and
TR:TREATMENT_SUMMARY             	liver tissue samples were harvested for further assays.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Serum samples were mixed with 4 volumes of acetonitrile, which contains 0.001
SP:SAMPLEPREP_SUMMARY            	mg/mL internal standard 4-chloro-DL-phenylalanine, to precipitate the proteins.
SP:SAMPLEPREP_SUMMARY            	After brief vortex mixing, the samples were incubated on ice for 15 min. The
SP:SAMPLEPREP_SUMMARY            	supernatants were collected after centrifuged at 20,000 g, 4 °C for 10 min,
SP:SAMPLEPREP_SUMMARY            	transferred to vials for LC-MS analysis.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	In this study, a newly developed precision-targeted metabolomics method with a
CH:CHROMATOGRAPHY_SUMMARY        	UPLC-TQ/MS system (Agilent 1290 Infnity, Agilent Technologies, USA; Agilent 6495
CH:CHROMATOGRAPHY_SUMMARY        	QQQ, Agilent Technologies, USA) in a DMRM scan-mode was applied to analyze the
CH:CHROMATOGRAPHY_SUMMARY        	metabolome of interest from trial samples (serum, liver tissues and stool).
CH:CHROMATOGRAPHY_SUMMARY        	Briefly, the method was performed with an ACQUITY UPLC HSS T3 column (2.1 mm
CH:CHROMATOGRAPHY_SUMMARY        	i.d. × 100 mm, 1.8 μm; Waters); mobile phase A and B were water and
CH:CHROMATOGRAPHY_SUMMARY        	acetonitrile with 0.1% formic acid (v/v) respectively. The flow rate was at 0.3
CH:CHROMATOGRAPHY_SUMMARY        	mL/min and the column temperature was maintained at 40 ℃. The samples were
CH:CHROMATOGRAPHY_SUMMARY        	placed in an auto-sampler maintained at 4 °C with a 5 μL injection volume. The
CH:CHROMATOGRAPHY_SUMMARY        	optimized gradient-elution program, as follows: 0-2 min, 98% A; 2-10 min, 98-65%
CH:CHROMATOGRAPHY_SUMMARY        	A; 10-12 min, 65-20% A; 12-14 min, 20-2% A; 14-30 min, 2% A.
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1290 Infinity
CH:COLUMN_NAME                   	ACQUITY UPLC HSS T3 column (2.1 mm i.d. × 100 mm, 1.8 μm; Waters)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6495 QQQ
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Agilent MassHunter Workstation Data Acquisition Agilent MassHunter
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	counts
MS_METABOLITE_DATA_START
Samples	20210323-C-1	20210323-C-2	20210323-C-4	20210323-C-5	20210323-C-7	20210323-C-8	20210323-AL-2	20210323-AL-3	20210323-AL-5	20210323-AL-6	20210323-AL-7	20210323-AL-8	20210323-AH-3	20210323-AH-4	20210323-AH-5	20210323-AH-6	20210323-AH-7	20210323-AH-8	20210323-CL-1	20210323-CL-2	20210323-CL-3	20210323-CL-4	20210323-CL-5	20210323-CL-6	20210323-CM-1	20210323-CM-2	20210323-CM-3	20210323-CM-4	20210323-CM-5	20210323-CM-6	20210323-CH-1	20210323-CH-2	20210323-CH-3	20210323-CH-4	20210323-CH-6	20210323-CH-7
Factors	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)
Citrate	192292.5253	118160.1673	107310.8009	17378.78884	39446.25508	84670.56485	81107.4082	13656.59023	499042.858	22462.63432	39209.13751	29179.88034	106446.389	246172.8164	52404.48	113242.7257	14968.5223	12678.00423	130393.0208	104462.984	126423.4496	84292.23067	150616.5544	38655.29915	65256.63038	69965.94771	94511.89096	196399.4212	43515.90775	551161.5386	59428.46724	89973.46662	149439.1238	167793.8623	186760.4581	292809.1176
Isocitric acid	178815.7549	91187.58768	96342.54997	23548.63535	36314.7504	53164.60295	46722.82852	12289.31844	422302.2866	26891.38538	27274.60783	24334.8625	91457.52219	227908.3341	52337.58422	58264.7356	13108.44979	6552.888929	92700.05316	83467.73683	108328.8658	117080.1865	101938.9417	20803.81905	80197.84673	57372.23541	83701.64479	176848.5395	52422.95692	596209.15	44782.68875	83992.56096	148456.108	108612.1633	159154.4687	264571.3763
Taurochenodeoxycholic acid	2198.020622	2617.025455	2329.291986	2953.925196	1984.597353	4051.032035	18661.72995	43301.67493	51904.28437	14993.91634	10176.91584	24215.66078	16405.94336	36469.05563	34573.27642	19042.76323	15947.37719	15288.478	5427.873731	48503.83938	3584.282723	4843.565502	2832.242289	5295.381392	16051.20613	7826.669749	9114.906831	34020.58117	6061.353777	399.1875479	4391.428785	8209.918224	7264.731948	17507.75437	5233.031985	3014.746167
P-Coumaric acid	32094.91171	10909.04469	13697.00333	7554.213078	9574.159659	12280.2012	15939.14402	24938.06921	16416.41966	27851.21471	13162.21367	17184.60112	40120.51531	13968.89126	8050.82042	5564.496258	33241.6453	10569.86442	74529.87665	15311.06007	53117.84967	16636.37178	36228.17388	15939.37179	42043.13826	101674.2313	65123.38782	81136.89192	60923.68143	5538.990617	68350.24113	103268.2679	66928.67313	73771.83752	85581.1241	126201.8616
Taurodeoxycholic acid	2215.746586	2617.025455	2329.291986	2953.437274	1984.597353	4076.934208	18661.72995	43301.67493	51858.18012	14993.91634	10172.7895	24215.66078	16405.94336	35496.48507	34570.5818	19044.38847	16403.97268	15288.478	5427.873731	48503.83938	3481.884398	4843.565502	2832.242289	5295.381392	16051.20613	7813.191425	9114.906831	34020.58117	6061.353777	399.1875479	4413.025478	8179.099653	6922.695644	17486.69067	5261.092812	2776.111003
L-Lactate	228290.6658	199771.4115	166466.9884	142916.577	159347.3657	171775.8808	294948.6191	212784.1006	293130.4748	236640.727	261239.6535	198021.6898	269504.0803	263226.1974	246048.767	279484.0395	205052.215	231583.0184	208553.3612	198606.1764	212386.6042	182997.4308	187148.7617	165005.6269	195162.96	201218.329	145603.5231	173979.2224	143924.3475	149743.9004	180575.2185	196311.1188	202058.3264	208829.0772	177377.3888	210249.65
Pyruvate	4339.721191	4704.739538	3978.65677	3183.490373	3793.328181	4355.505376	4358.358776	3191.094718	4755.601098	3545.679987	3512.166475	3220.718769	3941.083397	4657.734233	2198.451724	3852.067195	3235.728416	4098.742472	5226.545808	5787.385628	5729.406161	5070.741475	4812.37919	4913.562243	3218.954269	4443.42832	3619.00663	5590.741164	3794.03413	4222.707222	3634.911604	3137.697804	4277.853939	4281.302116	4262.861661	4477.042
2-Ketoglutaric acid	7780.676938	5577.253683	5889.131481	3200.471427	4607.369194	7218.106782	14434.5348	6946.567587	15818.62399	8119.104002	9744.548339	11064.10434	11632.51619	25174.21827	8181.163544	18696.44463	6579.957987	4974.302008	15489.44933	12544.14479	14770.22604	10761.9161	13736.73964	6960.762802	13679.84425	19604.99632	14433.91838	17125.38377	9412.532671	10834.14702	20042.773	17203.99145	20694.47414	24569.60404	17384.92337	29334.60358
Deoxycholic acid	300.2088779	701.2940497	939.976563	107.319466	515.7782457	1165.693293	762.8957893	1044.184796	3271.242409	1579.475666	2290.814162	1556.188999	765.3647408	1410.295652	656.1621607	756.996018	421.8714034	1129.62383	641.0939081	9249.396105	956.22493	3074.427264	1357.44102	2981.747128	3654.369704	3654.053528	2085.614487	5695.596746	1855.228344	300.7956193	191.5494246	218.8778062	585.5727476	404.1005793	635.1126626	695.1679252
Oxalic acid	33074.98978	30607.10416	25780.93861	20423.28139	24524.26245	28121.08717	43248.81982	31310.35865	43809.9745	34931.96634	36416.93413	28831.85155	41231.35437	42357.81187	33639.93324	46527.59146	30146.10583	34785.19009	32153.19146	31168.08339	31715.58519	26410.78537	29471.87104	24046.22943	30489.92011	32618.50945	22676.6626	24926.92665	22493.16697	22930.39356	27401.56172	31961.03307	29675.77517	32005.54396	25306.32018	31845.0087
Malonic acid	38098.01968	40189.50163	16342.94755	32440.60658	21781.36339	22229.32937	24309.24369	15151.09585	23839.44564	18389.61671	19028.86184	19468.26671	23685.64544	23197.35334	20460.9892	15185.15512	15980.7111	15954.66392	48994.27804	22384.16197	28687.91863	16550.50289	21819.64261	14806.79998	18597.60281	21490.33268	23758.76752	22921.89481	46510.43132	59934.16673	25285.5617	13551.82398	10745.87602	15138.50782	17175.71556	25455.2866
Azelaic acid	13145.68813	8131.061998	8087.879764	5837.097179	6606.858459	7660.174439	5122.95004	3153.743722	12323.55562	3870.91803	4472.818704	3706.180194	4376.795554	5329.776073	4263.720332	4509.719707	3634.388361	3372.949642	6634.135013	8686.646456	6142.618298	6175.58549	5145.243917	3992.433363	5852.713559	5335.647093	4988.772184	10712.03251	6302.405383	9746.113839	4043.862041	6523.908935	4466.888153	4120.064971	6214.260776	8434.932245
N-Acetyl-L-tryptophan	13252.56627	14321.4475	10868.85625	5146.122807	8289.467743	9890.101912	14416.74207	8282.059906	35174.78619	18389.06849	15173.15804	13426.09222	9401.919783	17699.20339	8082.601664	9741.260941	8179.554383	9730.436454	16931.39792	12659.45404	21248.23498	14392.61783	11525.76958	7823.876746	19193.34918	14181.44729	9749.571893	11163.09586	4689.393735	4411.997485	9402.340876	16135.98274	30730.70592	26298.43943	13709.72703	12652.294
Allantoin	4310.193859	3650.260237	3109.455971	2962.406597	3672.726867	4945.139989	10279.5567	7666.652738	6327.183611	14011.1379	8562.076727	10679.06986	7694.124119	7185.268466	8930.276781	11828.51668	9093.13525	10788.99124	3784.73003	3315.47149	4043.396371	3160.290143	4517.289193	4788.048669	7231.939863	5641.903662	6347.558874	4673.383819	2861.549833	2951.715877	13333.10374	9053.72523	6667.247767	6985.642775	7808.957567	7159.665765
Indoxyl sulfate	68903.07616	62005.51711	73778.91256	48157.14822	50301.64205	106165.9912	46789.78722	48447.2592	55643.41183	41808.99177	77057.66445	57656.98355	41723.80533	41915.77712	36357.59349	43952.07057	25206.75945	40085.2661	28023.13762	34219.76492	23863.40335	63619.18551	75984.7259	92242.7727	23298.9701	34990.0499	25035.60397	44120.96552	49366.2507	54103.99134	38665.3266	30752.76065	56109.65011	25223.91553	39715.34281	45617.2802
Malic acid	57377.33359	37603.57768	33322.24517	11124.93005	16245.7433	19144.89342	50091.12565	22305.75699	88825.56134	34278.76158	31429.18257	24701.56013	57966.07775	98455.22772	48452.06982	55579.0684	20514.35336	19171.5412	36766.68215	34770.23167	36835.0614	27313.23996	32383.59038	21107.04325	47434.65548	40826.03313	34355.56229	31168.63879	18115.40031	52791.86903	46455.87242	49712.35843	45257.68437	46179.79109	50047.82675	61164.44115
D-Fructose	14789.38598	12881.51959	17742.88661	12922.0204	14042.89753	18383.84249	25116.7809	18428.52099	25495.91501	18961.18855	21153.57963	18003.44119	29416.57314	27436.89444	30576.25331	36205.24168	19610.17257	23212.39843	31867.22604	28542.57365	32213.4022	24872.18288	22378.01165	26365.99312	32971.29478	31745.21178	18084.76483	24837.85911	18119.90115	19774.54067	34020.8793	28344.93747	32706.39827	33328.15675	24858.3689	31041.04311
Succinic acid	7131.292946	2871.383015	2429.103615	1068.766518	2505.477939	2613.016788	3336.167985	1628.871288	5539.249036	2012.82838	3158.228512	2049.892536	2795.004935	4181.681789	2598.060431	5525.252151	1282.89239	1056.028502	5662.683087	2617.501373	4645.176516	3430.605262	3687.901623	2577.356947	3386.977066	3220.492336	2155.87506	2936.41471	1880.713508	4462.767623	2399.072255	3080.773961	4123.793064	4732.879899	4401.330659	6314.279389
Glucose	27363.33975	27903.61951	26821.80724	19440.37138	18365.20195	27118.81674	43561.64997	32537.20814	51600.63824	37480.74082	36778.57164	27194.52739	52824.73273	45148.94038	40126.60487	43189.24105	31095.17381	38421.8957	49541.36524	41372.53057	46537.96796	35915.59107	34008.6172	23731.71502	54768.0933	45613.2383	30978.26657	33822.7311	24401.68882	27782.43262	33745.64165	45744.30211	42711.27702	45187.34049	32304.02421	41976.32261
2-hydroxy-2-phenylpropanoic acid	29132.46853	26378.97194	26636.09713	37134.81538	41076.0636	47536.99564	50801.88966	41838.13531	35896.85717	49671.70451	50417.43511	48896.61656	38949.48133	38464.4843	40153.18329	48465.71807	37144.12682	50307.53884	20222.00916	18138.84358	18433.15304	18003.17734	29950.28969	34747.24474	18381.7963	19682.33461	18793.63047	17050.4329	20334.9115	21571.05911	23495.92826	21030.6801	17045.53429	16752.13422	16807.35211	18792.19567
3-Hydroxyphenylpropionic acid	29508.33996	25687.71394	27003.67849	35747.71093	40531.8087	46359.3364	53178.23943	42717.34103	36339.8708	49836.64914	48548.48307	47700.23579	38207.13671	38433.68826	39899.29902	47054.86145	37770.05695	50012.6221	19750.28021	18963.34977	18321.17317	18597.90314	30593.78998	35653.95173	18519.88593	20048.83355	18591.52336	16987.99911	20699.05401	20992.8661	24301.85894	20749.64896	16508.14483	17725.79051	17064.83135	18937.46391
Docosahexaenoic acid	16908.55061	10318.01431	9288.369097	14973.43407	14341.84743	16281.95108	23311.53288	17033.79752	9353.498751	17475.90988	17619.1007	17969.38688	10685.48839	10264.42308	12990.61157	17322.46402	13411.5276	17416.48823	6594.653331	7530.624677	6164.291157	7446.408376	11035.78128	14721.01372	6507.597813	7587.805995	6824.162225	6995.526885	7470.953949	3352.491854	8673.465044	8452.494156	5505.496968	6455.185881	5845.798675	5482.833215
Phenyllactic acid	6439.157618	6060.065834	6255.995994	4233.785732	4139.360107	6040.386951	7976.05537	4915.800974	8881.116562	5296.554615	5891.9318	5072.665256	4727.733679	4510.439248	4595.878514	3423.210532	2821.54234	3664.349945	3739.031757	5247.287969	5302.984946	10240.22163	4886.651924	5125.155765	8801.358703	6690.937964	4195.448474	7358.111935	2775.01275	7535.140098	3523.667458	4926.46176	18848.5172	7391.958193	6260.845568	6177.426826
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	Polarity	m/z	RT
Citrate	Negative	191.11	1.51
Isocitric acid	Negative	191.02	1.43
Taurochenodeoxycholic acid	Negative	498.29	11.92
P-Coumaric acid	Negative	163.04	8.92
Taurodeoxycholic acid	Negative	498.29	13.12
L-Lactate	Negative	89.02	1.43
Pyruvate	Negative	87.01	2.33
2-Ketoglutaric acid	Negative	145.09	2.27
Deoxycholic acid	Negative	391.3	12.47
Oxalic acid	Negative	89	1.38
Malonic acid	Negative	103	0.85
Azelaic acid	Negative	187.1	9.62
N-Acetyl-L-tryptophan	Negative	245.09	10.29
Allantoin	Negative	157.03	0.96
Indoxyl sulfate	Negative	212	7.66
Malic acid	Negative	133.01	1.29
D-Fructose	Negative	179.05	2.35
Succinic acid	Negative	117.02	2.94
Glucose	Negative	179.05	1.92
2-hydroxy-2-phenylpropanoic acid	Negative	165.05	7.06
3-Hydroxyphenylpropionic acid	Negative	165.05	7.05
Docosahexaenoic acid	Negative	327.23	14.27
Phenyllactic acid	Negative	165.05	8.55
METABOLITES_END
#END